Bonanno et al. [30], in fact, reported that the levels of kynurenine in sera and BM fluid collected from MM patients and the expression of indoleamine 2,3-dioxygenase 1 (IDO1) in neoplastic cells were higher than those in normal controls. This evidence concerns the gene IDO1 and Miyoshi myopathy.